⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

VCYT

Veracyte, Inc.

Healthcare · Diagnostics & Research

43.86USD

+1.4100 (+3.32%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Valuation

P/E (TTM)

30.80x

P/E (Forward)

22.46x

EV/EBITDA

24.34x

EV/Revenue

5.48x

P/S (TTM)

6.28x

P/B

2.54x

FCF Yield

4.71%

Dividend Yield

0.00%

Gross Margin

71.71%

Operating Margin

18.82%

Net Margin

20.37%

Peer Comparison — Diagnostics & Research

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
VCYTVeracyte, Inc.$3.53B30.80x24.34x4.71%15.49%0.00%
TMOThermo Fisher Scientific Inc.$223.95B32.62x22.37x2.79%10.50%0.31%

Subject metrics from SEC filings where available; peer metrics from cached market data.

DHRDanaher Corporation
$144.01B
36.58x
20.90x
3.00%
5.50%
0.78%
IQVIQVIA Holdings Inc.$42.30B31.96x18.69x5.08%8.70%—
AAgilent Technologies, Inc.$40.81B28.55x21.05x2.60%8.10%0.69%
IDXXIDEXX Laboratories, Inc.$40.58B36.15x25.58x2.24%9.70%—
WATWaters Corporation$39.75B102.48x30.66x-0.36%113.40%—
ILMNIllumina, Inc.$30.95B38.25x27.98x2.58%9.40%—
LHLabcorp Holdings Inc.$26.04B26.58x14.11x3.43%5.80%0.89%